EXPANDED METHODS

Oligonucleotide synthesis
Oligonucleotides and the library containing AEGIS nucleotides were prepared as previously reported (9,10) by solid phase phosphoramidite synthesis using standard nucleoside phosphoroamidites (Bz-dA, Ac-dC, dmf-dG, and dT, from Glen Research, Sterling, VA) and AEGIS phosphoramidites (Firebird Biomolecular Sciences LLC, Alachua, FL). CPG having standard nucleosides was from Glen Research. Solid phase synthesis was performed using an ABI 394 DNA Synthesizer following standard phosphoramidite chemistry procedures. The randomized sites in the library were prepared by coupling with a 1:1:1:1:1:1 mixture of the six (GACTZP) nucleotide phosphoramidites. After synthesis was complete, the solid phases carrying the protected synthetic oligonucleotides were treated with concentrated NH 4 OH (55 °C, 16 h).
After evaporation of the NH 4 OH, the oligonucleotides were purified by ion-exchange HPLC, and then desalted using Sep-Pac® Plus C18 cartridges (Waters).
In vitro selection scheme
A synthetic library of GACTZP oligonucleotides (59 nucleotides in length) containing 25 randomized positions flanked by two primer binding sites (17 nt each) was used to start the AEGIS laboratory in vitro evolution (AEGIS-LIVE) experiment. The library was 59 nucleotides in length, with sequence: 5'-AGAGAGCGTCGTGTGGA-N25-TGAGGAGGTGCGCAAGT-3'.
The initial step was a negative selection on the magnetic beads lacking PA. Protective antigen (PA63) was presented immobilized on magnetic beads (Dynabeads M-270 Carboxylic Acid, Invitrogen), binding oligonucleotides were recovered magnetically, and AEGIS-PCR (9,10) with a single biotinylated primer was performed directly on survivors bound to the bead-coupled PA63. For selection negative cycle I and selection cycle I, 5'-labeled and PAGE-purified ssDNA library (1 nmole) was used. Carboxylated magnetic beads (Dynabeads M-270 carboxylic acid, Invitrogen) were coated with PA63 (List Biologicals) following the manufacturer protocol, and nonreacted sites were blocked with ethanolamine. A mock coating process without PA63 was also performed on the beads to support negative selection cycles. ssDNA was denatured/renatured in 1X PBS at 80°C for 5 min followed by slow cooling to RT (0.1°C/second). Folded ssDNA was incubated with uncoated beads for 30 min at RT (negative cycle I). Beads were then collected on a magnet and the supernatant transferred to PA-coated beads. Uncoated beads were washed once with 1X PBS and this supernatant added to the binding reaction. Binding reactions were carried over for 30 min at RT. Subsequently, beads were collected and washed extensively with 1X PBS, until no radioactive signal could be detected in the washes. All fractions were then read with Cherenkov counting at a scintillation counter (Perkin Elmer TriCarb 2900TR). Negative cycle I and cycle I of the selection were performed using 1 nmole library and 3 nmoles PA63; all other cycles were performed with 150 pmoles ssDNA and 800 pmoles PA63. In vitro selection included fourteen cycles, at which point the library was prepared for conversion and deep sequencing.
AEGIS-DNA to standard DNA transliteration for high-throughput sequencing
Survivors of Cycle XIV were divided in two aliquots and PCR amplified under conditions that transliterated the Z:P pairs to C:G or T:A pairs in approximately equal amount (9,12). Tags and barcodes were then added by 12 cycles of PCR with tagged primers. The amplified products were purified by native PAGE, recovered by gel-extraction, and the collection of amplicons was submitted for Ion Torrent deep sequencing, according to the sequencing center guidelines. Twelve cycles of PCR amplification were then carried out for each sequencing conditions.
High-throughput sequencing
Following conversion, the barcoded samples were combined and submitted for Ion Torrent deep sequencing. Ion torrent analysis was performed as previously reported (9,10). Reads missing exactly matched barcodes and/or forward and reverse priming sequences were discarded. To minimize miscalling, sequences present at 20 or fewer copies in the library were removed from the subsequent analysis. The remaining reads (~2 x 10 6 in total) were clustered using a custom algorithm. This algorithm ignored differing barcodes, concentrating only on the variable 25 nucleotide region. Due to the short sequence size and unknown number of converted sites, sequence clusters were created in a step-wise process by grouping those with a single base change between sequence reads, starting with the most common sequence read and proceeding towards the least common. This was an iterative algorithm, meaning that sequences with a single-base difference from any other sequence in the cluster were continued to be added to the cluster until no further sequences could be added. Clustered sequences were then separated by barcode, and variable sites were compared between each barcode. The clustered sequences obtained under the first conversion conditions (Z to C and P to G) serve as reference for the clustered sequences obtained under the second.
Determination of the affinity constant with bead-based assay
After being coupled to PA63 (~1.6 nmoles), the beads (200 µL, as during selection) were divided into aliquots (20 µL each) and each fraction was incubated with increasing concentrations of pre-folded cold PA1, spiked with 1 µL (> 13 pM) of 5' 32 P-PA1. Concentrations of aptamer [A] were: >13 pM, 10 nM, 20 nM, 50 nM, 100 nM, 200 nM, 0.5 µM, 1 µM, 2 µM. Binding mixtures were tumbled (RT, 45 min), and the beads were recovered with a magnet. The supernatant was collected for cpm reading. Beads were washed 2 times with 100 µL 1X binding buffer (1X PBS), and all the fractions were separately read with liquid scintillation. Radioactivity readings of the samples aptamers+PA-beads were analyzed as follows:
First, the following assumptions were made:
at 2 µM aptamer concentration, each PA molecule on the beads has 1 aptamer molecule bound -adding the labeled aptamer to the measured amounts of non-labeled aptamers does not materially change the concentration of the aptamers.
The beads do not materially quench the scintillation counting signal.
labeled and unlabeled aptamer bind the same way Under these assumption, taken the cpm at 2 µM as a starting point "cpm2", cpm at 1 µM should be cpm2 X 2, cpm at 0.5 µM should be cpm1 X 2, cpm at 200 nM should be cpm 0.5 X 2.5, and so on.
Dividing the actual cpm read for each sample by the expected cpm for that sample, we obtain the Fraction of PA molecules on the beads that actually have one aptamer bound (C/P 0 , or
. The reciprocal of this number is P 0 /C. Plotting P 0 /C versus the reciprocal of aptamer concentration (1/[A]) will give a line the slope of which represents the K diss value (K in this derivatization). The described stepwise calculation is as follows:
Bead-based binding assay on CMG2-PA complex PA63 (1 nmole) was incubated with biotinylated CMG2 (1 nmole) in buffer (20 mM Tris pH 7.5, 1 mM MgCl 2 ) at RT to give complex (1 nmole). The complex was adsorbed to magnetic beads bearing streptavidin (300 µL, Invitrogen). This corresponds to 600 pmoles of bound complex (the manufacturer's described binding capacity is ~ 2 pmoles/µL). After adsorption and washing according to manufacturer instructions, aliquots of the beads were placed in 10 tubes.
Unlabeled aptamer (pre-folded in 1X PBS) spiked with 0.1 nM 5'-labeled aptamer (also prefolded) was added at increasing concentrations to the beads, and the mixtures were incubated at RT (45 min). The supernatants were then collected, the beads were washed twice (1X PBS), and all fractions were dissolved in scintillation cocktail for cpm reading. For each aptamer concentration, the percent bound of the labeled species was calculated by counting cpm of bound molecules (times 100) and dividing by total cpm for that sample (bound + supernatant + washes). 
